1-4 of 4
David Ritchie, MBChB, FRACP, FRCPA, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Regulatory T Cells (Treg) Are Depressed in Patients with Relapsed/Refractory Multiple Myeloma (MM) and Increases towards Normal Range in Responding Patients Treated with Lenalidomide (LEN).

Hang Quach, MB, BS, FRACP, FRCPA, David Ritchie, MBChB, FRACP, FRCPA, PhD, Paul Neeson, PhD, Simon Harrison, MB, BS, MRCP, MRCPath, PhD, Tsin Tai, MSc, Kellie Tainton, BSc, Kevin Lynch, MB, BS, FFPM, Miles Prince, MB, BS, FRACP, FRCPA, MRACMA, MD
Journal: Blood
Blood (2008) 112 (11): 1696.
https://doi.org/10.1182/blood.V112.11.1696.1696
Published: 2008
Journal Articles

A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML

Andrew W. Roberts, MBBS, PhD, Simon He, MBBS, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, Mark S Hertzberg, MBBS, FRACP, FRCP, PhD, Simon T S Durrant, MRCS, MBBS, MRCP, FRCP, David Ritchie, MBChB, FRACP, FRCPA, PhD, Ian D. Lewis, MBBS, PhD, FRACP, FRCPA, Paula Marlton, MBBS, FRACP, FRCPA, Andrew J McLachlan, PhD, Trina M Yeadon, PhD, Samantha J Busfield, PhD, Megan J Barnden, PhD, Roslyn Davis, BSc(Hons), Sarah Hosback, PhD, Danijela Mirosa, PhD, Mark Biondo, PhD, Simone Bamford, MBBS, FRACGP, Mark DeWitte, VMD, Russell Basser, MBBS, MD, FRACP
Journal: Blood
Blood (2008) 112 (11): 2956.
https://doi.org/10.1182/blood.V112.11.2956.2956
Published: 2008
Journal Articles

The Addition of Systemic High-Dose Methotrexate (HD-MTX) to Intrathecal Chemotherapy (IT) for Central Nervous System (CNS) Prophylaxis Substantilly Reduces CNS Recurrence Rates in Patients with at-Risk Aggressive Lymphoma: A Historically Controlled Prospective Study

Kirsten Herbert, MBBS, FRACP, PhD, Max Wolf, MBBS, FRACP, FRCPA, Dennis Carney, MBBS, FRACP, FRCPA, David Alan Westerman, MBBS, FRACP, FRCPA, Henry Januszewicz, MBBS, FRACP, FRCPA, Simon Harrison, MBBS, PhD, David Ritchie, MBChB, FRACP, FRCPA, PhD, H. Miles Prince, John Francis Seymour, MBBS, FRACP, PhD
Journal: Blood
Blood (2008) 112 (11): 3596.
https://doi.org/10.1182/blood.V112.11.3596.3596
Published: 2008
Journal Articles

High Response Rates with the Combination of Bortezomib, Dexamethasone and the Pan-Histone Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma in a Phase I/II Clinical Trial

Simon James Harrison, MBBS, MRCP, MRCPath, PhD., Hang Quach, MB, BS, FRACP, FRCPA, Kally Yuen, Andrew Strayer, Michael C. Copeman, DPhil, FRACP, S. Peinert, M. Bishton, M. Wolf, H. Januszewicz, MK Kenealy, K. Herbert, David Westerman, D. Carney, J. F Seymour, R. W Johnstone, David Ritchie, MBChB, FRACP, FRCPA, PhD, Miles Prince, MD
Journal: Blood
Blood (2008) 112 (11): 3698.
https://doi.org/10.1182/blood.V112.11.3698.3698
Published: 2008